Actively Recruiting
Evaluating Accelerated Brain Stimulation Using BTL-699-2 for Adults with Generalized Anxiety Disorder
Led by BTL Industries Ltd. · Updated on 2026-09-18
40
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of the BTL-699-2 device, which delivers non-invasive repetitive transcranial magnetic stimulation, to see if it can reduce anxiety symptoms in adults aged 22 and older diagnosed with Generalized Anxiety Disorder GAD. The study compares an active treatment group receiving up to 80% of their motor threshold stimulation to a sham group receiving minimal stimulation, focusing on changes in anxiety symptoms and safety over three months after treatment. Participants will attend a screening visit to confirm GAD diagnosis and determine their motor threshold. They will then complete eight treatment visits over approximately four weeks, each including two 19-minute stimulation sessions spaced at least 15 minutes apart. One group will receive active stimulation, while the other receives sham treatment at a very low intensity. Follow-up visits will occur at one month and three months after treatment to assess long-term effects and safety. During the study, participants will complete questionnaires about anxiety, depression, well-being, suicidal risk, clinical improvement, and treatment satisfaction at baseline, during treatment, and at follow-ups. Women of childbearing potential will have urine pregnancy tests at baseline and weekly during treatment. Researchers will monitor changes in self-reported anxiety symptoms as the primary outcome, along with secondary measures of depressive symptoms, clinician assessments, and safety over the study period lasting around four months.
CONDITIONS
Brief Title
Device for Treating Generalized Anxiety
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here